U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea · Delayed Price · Currency is KRW 20,750
-1,850 (-8.19%)
At close: Mar 19, 2026
486.16% (1Y)
| Market Cap | 302.72B +870.0% |
| Revenue (ttm) | 25.59B +2.2% |
| Net Income | -1.64B |
| EPS | -141.00 |
| Shares Out | 15.93M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 100.00 (0.43%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 412,432 |
| Average Volume | 2,828,722 |
| Open | 22,150 |
| Previous Close | 22,600 |
| Day's Range | 20,500 - 22,500 |
| 52-Week Range | 2,850 - 32,800 |
| Beta | 1.74 |
| RSI | 49.78 |
| Earnings Date | n/a |